FAM164A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.915200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.412800E-01
Normal-vs-Stage2
6.789200E-01
Normal-vs-Stage3
1.482800E-01
Normal-vs-Stage4
7.703000E-01
Stage1-vs-Stage2
5.782000E-01
Stage1-vs-Stage3
3.002400E-01
Stage1-vs-Stage4
2.189600E-01
Stage2-vs-Stage3
1.975600E-01
Stage2-vs-Stage4
3.517800E-01
Stage3-vs-Stage4
1.224370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.419200E-01
Normal-vs-AfricanAmerican
2.206600E-01
Normal-vs-Asian
8.812000E-01
Caucasian-vs-AfricanAmerican
4.897600E-01
Caucasian-vs-Asian
8.029400E-01
AfricanAmerican-vs-Asian
4.399800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.279200E-01
Normal-vs-Female
6.583000E-01
Male-vs-Female
8.338800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.239400E-01
Normal-vs-Age(41-60Yrs)
9.872400E-01
Normal-vs-Age(61-80Yrs)
6.120400E-01
Normal-vs-Age(81-100Yrs)
1.436040E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.388400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.307800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.327400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.215500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.081710E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.408450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.826200E-01
Normal-vs-Daily Drinker
7.157800E-01
Normal-vs-Weekly Drinker
4.062600E-01
Normal-vs-Occasional Drinker
6.582000E-01
Normal-vs-Social Drinker
7.132400E-01
Non Drinker-vs-Daily Drinker
3.838800E-01
Non Drinker-vs-Weekly Drinker
7.575200E-01
Non Drinker-vs-Occasional Drinker
2.998000E-02
Non Drinker-vs-Social Drinker
5.368200E-01
Daily Drinker-vs-Weekly Drinker
6.256200E-01
Daily Drinker-vs-Occasional Drinker
1.225370E-01
Daily Drinker-vs-Social Drinker
9.429400E-01
Weekly Drinker-vs-Occasional Drinker
5.664400E-02
Weekly Drinker-vs-Social Drinker
7.144800E-01
Occasional Drinker-vs-Social Drinker
1.676380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.724010E-01
Normal-vs-Grade 2
4.303900E-02
Normal-vs-Grade 3
6.475900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.785980E-01
Grade 1-vs-Grade 3
1.365850E-01
Grade 1-vs-Grade 4
1.724010E-01
Grade 2-vs-Grade 3
5.533600E-01
Grade 2-vs-Grade 4
4.303900E-02
Grade 3-vs-Grade 4
6.475900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.726800E-01
Normal-vs-NonDiabetic
7.593600E-01
Diabetic-vs-NonDiabetic
3.259400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.267000E-01
Normal-vs-NoPancreatitis
7.084600E-01
Pancreatitis-vs-NoPancreatitis
6.382000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.439600E-01
Normal-vs-N1
6.638200E-01
N0-vs-N1
9.389400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.921000E-01
Normal-vs-TP53-NonMutant
3.001600E-01
TP53-Mutant-vs-TP53-NonMutant
2.522600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
